Conditions

close

result 20966 件

JaLCDOI 10.18926/AMO/48078
FullText URL 66_1_23.pdf
Author Watanabe, Toyohiko| Inoue, Miyabi| Ishii, Ayano| Yamato, Toyoko| Yamamoto, Masumi| Sasaki, Katsumi| Kobayashi, Yasuyuki| Araki, Motoo| Uehara, Shinya| Saika, Takashi| Kumon, Hiromi|
Abstract Polypropylene mesh implants for the correction of pelvic organ prolapse (POP) are now available in Japan. We developed an innovative approach for correcting POP by placing polypropylene mesh transvaginally with laparoscopic assistance. From June 2007 through March 2010, sixteen consecutive patients with symptomatic stage 2 or 3 pelvic organ prolapse underwent the laparoscopic-assisted tension-free vaginal mesh procedure at Okayama University Hospital. All patients were evaluated before and at 1, 3, 6, and 12 months after surgery. Female sexual function was also evaluated with the Female Sexual Function Index (FSFI). The procedure was performed successfully without significant complications. Fifteen of 16 patients were considered anatomically cured (93.8%) at 12 months postoperatively. One patient with a recurrent stage 3 vaginal vault prolapse required sacral colpopexy six months postoperatively. Total FSFI scores improved significantly from 10.3±1.3 at baseline to 18.0±1.2 at 12 months after surgery. The laparoscopic-assisted trans-vaginal mesh is a safe, effective, and simple procedure for POP repairs. The procedure not only restores anatomic relationships but also improves sexual function.
Keywords tension-free vaginal mesh pelvic organ prolapse laparoscopic female urology sexual function
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2012-02
Volume volume66
Issue issue1
Publisher Okayama University Medical School
Start Page 23
End Page 29
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2012 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 22358136
Web of Science KeyUT 000300800700004
JaLCDOI 10.18926/AMO/48077
FullText URL 66_1_17.pdf
Author Hayashida, Keiichi| Takeda, Yoshihiro| Katsuda, Toshizo| Yamamoto, Kenyu| Suesada, Yasuhide| Shibata, Moeko| Azuma, Masami|
Abstract Proximal femoral bone mineral density (BMD) can be measured by dual energy X-ray absorptiometry method in the neck, trochanter, intertrochanter, total and Ward's triangle area. Ward's triangle area of the proximal femur is a smaller area to measure than the others, and the position varies, depending on the status of inner rotation of the target leg. In this study, the measurements of the proximal femoral BMD in women were carried out on the neck, trochanter, intertrochanter, total and Ward's triangle area with the, subjects' legs turned 15 degrees toward the inside. The Ward's BMD were measured using Ward's cognitive method, in which the measured BMD were compared among age groups of 50-59, 60-69, 70-79 and 80-89 to determine whether this process could reveal decreased femoral BMD in elderly women. The correlation between BMD and age was tested using the Pearson correlation coefficient. In all measured parts, the BMD of women age 50-59 were significantly higher than those of women age 80-89. The correlations between BMD and age were negative in all measured parts, and the most negative correlation was between age and Ward's BMD. The study using Ward's cognitive method showed an inverse correlation between Ward's BMD and age in women.
Keywords proximal femoral BMD dual energy X-ray absorptiometry Wardʼs BMD Wardʼs cognitive method
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2012-02
Volume volume66
Issue issue1
Publisher Okayama University Medical School
Start Page 17
End Page 21
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2012 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 22358135
Web of Science KeyUT 000300800700003
JaLCDOI 10.18926/AMO/48076
FullText URL 66_1_7.pdf
Author Kawauchi, Keiichiro| Watanabe, Masami| Kaku, Haruki| Huang, Peng| Sasaki, Kasumi| Sakaguchi, Masakiyo| Ochiai, Kazuhiko| Huh, Nam-ho| Nasu, Yasutomo| Kumon, Hiromi|
Abstract The preclinical safety and therapeutic efficacy of adenoviral vectors that express the REIC/Dkk-3 tumor suppressor gene (Ad-REIC) was examined for use in prostate cancer gene therapy. The Ad-human (h) and mouse (m) REIC were previously demonstrated to induce strong anti-cancer effects in vitro and in vivo, and we herein report the results of two in vivo studies. First, intra-tumor Ad-hREIC administration was examined for toxicity and therapeutic effects in a subcutaneous tumor model using the PC3 prostate cancer cell line. Second, intra-prostatic Ad-mREIC administration was tested for toxicity in normal mice. The whole-body and spleen weights, hematological and serum chemistry parameters, and histological evaluation of tissues from throughout the body were analyzed. Both experiments indicated that there was no significant difference in the examined parameters between the Ad-REIC-treated group and the control (PBS- or Ad-LacZ-treated) group. In the in vitro analysis using PC3 cells, a significant apoptotic effect was observed after Ad-hREIC treatment. Confirming this observation, the robust anti-tumor efficacy of Ad-hREIC was demonstrated in the in vivo subcutaneous prostate cancer model. Based on the results of these preclinical experiments, we consider the adenovirus-mediated REIC/Dkk-3 in situ gene therapy to be safe and useful for the clinical treatment of prostate cancer.
Keywords REIC Dickkopf-3 gene therapy prostate cancer preclinical study
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2012-02
Volume volume66
Issue issue1
Publisher Okayama University Medical School
Start Page 7
End Page 16
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2012 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 22358134
Web of Science KeyUT 000300800700002
JaLCDOI 10.18926/AMO/48075
FullText URL 66_1_1.pdf
Author Udono, Heiichiro|
Abstract Dendritic cells (DCs) take up soluble- or cell-associated antigens and digest them, delivering fragments to the MHC class I pathway to display antigenic peptides to CD8+ T cells, a process known as cross-presentation. The pathway requires that, in order to be degraded by proteosomes, the extracellular antigens must have access to the cytosol across the endosomal membranes. Although the cross-presentation phenomena was first identified in the 1970s, the molecular mechanism responsible for the translocation is still not fully understood. In this context, we have recently found that cytosolic heat shock protein (HSP)90 translocates internalized antigen to the cytosol in DCs. Our results revealed the important role that cytosolic HSP90 plays in cross-presentation by pulling out endosomal antigen to the cytosol.
Keywords heat shock protein 90 dendritic cells cross-presentation proteasome cytotoxic T cell immunity
Amo Type Review
Publication Title Acta Medica Okayama
Published Date 2012-02
Volume volume66
Issue issue1
Publisher Okayama University Medical School
Start Page 1
End Page 6
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2012 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 22358133
Web of Science KeyUT 000300800700001
Author 上坂 熊勝| 關 正次|
Published Date 1918-10-31
Publication Title 岡山医学会雑誌
Volume volume30
Issue issue345
Content Type Journal Article
Author 野上 尚志|
Published Date 1918-09-30
Publication Title 岡山医学会雑誌
Volume volume30
Issue issue344
Content Type Journal Article
Author 久保 信之|
Published Date 1918-08-31
Publication Title 岡山医学会雑誌
Volume volume30
Issue issue343
Content Type Journal Article
Author 田中 文男|
Published Date 1918-07-31
Publication Title 岡山医学会雑誌
Volume volume30
Issue issue342
Content Type Journal Article
Author 伊達 久彦|
Published Date 1918-06-30
Publication Title 岡山医学会雑誌
Volume volume30
Issue issue341
Content Type Journal Article
Author 龜山 晋|
Published Date 1918-04-30
Publication Title 岡山医学会雑誌
Volume volume30
Issue issue339
Content Type Journal Article
Author 池田 嘉一郎|
Published Date 1918-03-31
Publication Title 岡山医学会雑誌
Volume volume30
Issue issue338
Content Type Journal Article
Author 横川 定|
Published Date 1918-02-28
Publication Title 岡山医学会雑誌
Volume volume30
Issue issue337
Content Type Journal Article
Author 横川 定|
Published Date 1918-01-31
Publication Title 岡山医学会雑誌
Volume volume30
Issue issue336
Content Type Journal Article
Author 田邊 於兎|
Published Date 1919-11-30
Publication Title 岡山医学会雑誌
Volume volume31
Issue issue358
Content Type Journal Article
Author 田村 於兎|
Published Date 1919-10-31
Publication Title 岡山医学会雑誌
Volume volume31
Issue issue357
Content Type Journal Article
Author 田丸 要槌|
Published Date 1919-09-30
Publication Title 岡山医学会雑誌
Volume volume31
Issue issue356
Content Type Journal Article
Author 田中 文男|
Published Date 1919-08-31
Publication Title 岡山医学会雑誌
Volume volume31
Issue issue355
Content Type Journal Article
Author 高祖 敏雅|
Published Date 1919-06-30
Publication Title 岡山医学会雑誌
Volume volume31
Issue issue353
Content Type Journal Article
Author 田村 於兎|
Published Date 1919-05-31
Publication Title 岡山医学会雑誌
Volume volume31
Issue issue352
Content Type Journal Article
Author 久保 信之|
Published Date 1919-04-30
Publication Title 岡山医学会雑誌
Volume volume31
Issue issue351
Content Type Journal Article